gamlpv
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 13, 2017 (NCT03137927)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human papillomavirusImmunity, active
Human papillomavirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gamlpv
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04036526 | Phase 1/Phase 2 (Phase 2) | Jun 4, 2019 | Government of Russia, Moscow Healthcare Department |
| NCT03137927 | Phase 1 | Jun 13, 2017 | Government of Russia, Moscow Healthcare Department |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of Russia | Government | 2 | 2 | 2 | 2017 |
| Moscow Healthcare Department | Academic/Hospital | 2 | 0 | 2 | 2017 |
2 organizations
Page 1 / 1